Furthermore, cisplatin-resistant NSCLC tissues displayed higher expression of TRIM65 mRNA and lower expression of miR-138-5p as compared to cisplatin non-resistant ones. The gene discussed is TRIM65; the disease is non-small cell lung carcinoma.